Announcements Trials
Browse Landscape

Status

Recruiting 281Active not recruiting 202Completed 157Terminated 71Not yet recruiting 43Withdrawn 10Enrolling by invitation 7Suspended 5No longer available 3Available 3

Sponsor Class

INDUSTRY 3

Study Type

Expanded_access 3

Sponsor

Cancer Type

Dermatologic 3

Conditions

Carcinoma, Non-Small-Cell Lung 4Multiple Myeloma 3Melanoma 3Lung Neoplasms 3Recurrence 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Neuroblastoma 2Neoplasms 2Glioblastoma 2Wilms Tumor 1Uterine Neoplasms 1Urogenital Neoplasms 1Triple Negative Breast Neoplasms 1Thoracic Neoplasms 1Stomach Neoplasms 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Pinealoma 1Ovarian Neoplasms 1Osteosarcoma 1Neuroectodermal Tumors, Primitive 1Neoplasms by Site 1Meningeal Neoplasms 1

Interventions

trametinib 1dabrafenib 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
No longer available × Melanoma × 1 year × Clear all
NCT06063746 2026-01-08

Compassionate Use of Vidutolimod

Regeneron Pharmaceuticals

No longer available
Dermatologic

Melanoma

NCT04489433 2025-12-18

Compassionate Use Program to Access Trametinib and Dabrafenib for Patients With BRAF Mutation-positive Metastatic Melanoma

Novartis

No longer available
Dermatologic

Melanoma

NCT06590480 2025-12-18

RPL-EAP-001

Replimune, Inc.

No longer available
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡